DK1328289T3 - Oxiderede proteiner og deres biologiske og terapuetiske aktivitet samt diagnostisk anvendelse ved hæmning af interaktion mellem oxiderede proteiner og CD36 - Google Patents

Oxiderede proteiner og deres biologiske og terapuetiske aktivitet samt diagnostisk anvendelse ved hæmning af interaktion mellem oxiderede proteiner og CD36

Info

Publication number
DK1328289T3
DK1328289T3 DK01983562T DK01983562T DK1328289T3 DK 1328289 T3 DK1328289 T3 DK 1328289T3 DK 01983562 T DK01983562 T DK 01983562T DK 01983562 T DK01983562 T DK 01983562T DK 1328289 T3 DK1328289 T3 DK 1328289T3
Authority
DK
Denmark
Prior art keywords
oxidized proteins
biological
well
therapeutic activity
diagnostic use
Prior art date
Application number
DK01983562T
Other languages
Danish (da)
English (en)
Inventor
Beate Kehrel
Martin Brodde
Original Assignee
Hamburger Stiftung Zur Foerder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10051983A external-priority patent/DE10051983A1/de
Priority claimed from DE2001148624 external-priority patent/DE10148624A1/de
Application filed by Hamburger Stiftung Zur Foerder filed Critical Hamburger Stiftung Zur Foerder
Application granted granted Critical
Publication of DK1328289T3 publication Critical patent/DK1328289T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
DK01983562T 2000-10-20 2001-10-19 Oxiderede proteiner og deres biologiske og terapuetiske aktivitet samt diagnostisk anvendelse ved hæmning af interaktion mellem oxiderede proteiner og CD36 DK1328289T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10051983A DE10051983A1 (de) 2000-10-20 2000-10-20 Inhibierung der pathogenen Wirkung oxidierter Proteine
DE2001148624 DE10148624A1 (de) 2001-10-02 2001-10-02 Oxidierte Proteine - ihre biologische Wirkung, sowie therapeutische und diagnostische Maßnahmen, die sich aus dem Wirkmechanismus, dem Einsatz dieser Proteine oder deren Inhibierung ableiten
PCT/EP2001/012129 WO2002032445A2 (de) 2000-10-20 2001-10-19 Hemmung der interaktion zwischen oxidierte proteine und cd36 oder dessen wirkmechanismus

Publications (1)

Publication Number Publication Date
DK1328289T3 true DK1328289T3 (da) 2008-12-15

Family

ID=26007431

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01983562T DK1328289T3 (da) 2000-10-20 2001-10-19 Oxiderede proteiner og deres biologiske og terapuetiske aktivitet samt diagnostisk anvendelse ved hæmning af interaktion mellem oxiderede proteiner og CD36

Country Status (14)

Country Link
EP (2) EP1328289B1 (es)
JP (1) JP4881535B2 (es)
AP (2) AP2781A (es)
AT (1) ATE406908T1 (es)
AU (1) AU2002215032A1 (es)
CA (1) CA2453140C (es)
CY (1) CY1110418T1 (es)
DE (1) DE50114289D1 (es)
DK (1) DK1328289T3 (es)
ES (1) ES2307662T3 (es)
HK (1) HK1057857A1 (es)
OA (1) OA12431A (es)
PT (1) PT1328289E (es)
WO (1) WO2002032445A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2375601T3 (es) * 2003-04-25 2012-03-02 Hamburger Stiftung Zur Förderung Von Wissenschaft Und Kultur Lucha contra infecciones por virus de ih con plasma sangu�?neo humano oxidado con �?cido hipocloroso.
EP3549594A1 (en) * 2005-09-16 2019-10-09 Cornell Research Foundation, Inc. Aromatic-cationic peptide for use in a method for reducing cd36 expression
JP2010235447A (ja) * 2007-07-30 2010-10-21 Igaku Seibutsugaku Kenkyusho:Kk 炎症性サイトカインの抑制剤
DE102010043733A1 (de) 2010-11-10 2012-05-10 Oxprotect Gmbh Unbeladene PEGylierte Liposomen zur Verwendung als Arzneimittel zur Prophylaxe und Therapie von hämorrhagischen und thrombo- embolischen Erkrankungen
DE102011003936A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Verwendung von Proteinen/Peptiden, welche an GRP78 (BIP) binden, in Labormethoden zum Monitoring von Thrombozyten-Aggregationshemmern
DE102011003944A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819923A1 (de) * 1988-06-11 1989-12-21 Behringwerke Ag Fibrin(ogen)derivate, verfahren zu ihrer herstellung und ihre verwendung
CA2067364A1 (en) * 1989-10-06 1991-04-07 Eric T. Fossel Oxidized lipoproteins and methods for their preparation
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
AU7185191A (en) * 1990-01-08 1991-08-05 Schering Corporation Oxidized variants of gm-csf
CA2086921A1 (en) * 1990-07-18 1992-01-19 Eric T. Fossel Method for treating viral infections using oxidized lipoproteins
EP0728019A4 (en) 1993-11-08 1999-07-07 Peptide Delivery Systems Pty L MARKED DIAGNOSTIC COMPOSITIONS AND METHODS OF USE THEREOF
RU2089179C1 (ru) * 1995-12-14 1997-09-10 Закрытое акционерное общество "ВАМ" Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
ATE385575T1 (de) 1997-06-20 2008-02-15 Leuven Res & Dev Versuchsanordnungen, antikörper und standards für den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte
GB9806632D0 (en) * 1998-03-28 1998-05-27 Stevenson Robert Peptide factor
WO2000028072A1 (en) * 1998-11-06 2000-05-18 Emory University Biomarkers for oxidative stress
DE10045047A1 (de) * 2000-09-12 2002-03-21 Beate Kehrel Arzneimittel enthaltend aktiviertes Antithrombin III

Also Published As

Publication number Publication date
EP1994941A2 (de) 2008-11-26
DE50114289D1 (de) 2008-10-16
AP2781A (en) 2013-10-31
OA12431A (en) 2006-04-19
EP1328289A2 (de) 2003-07-23
AP2009004857A0 (en) 2009-06-30
ATE406908T1 (de) 2008-09-15
AU2002215032A1 (en) 2002-04-29
CA2453140A1 (en) 2002-04-25
CY1110418T1 (el) 2015-04-29
PT1328289E (pt) 2008-12-10
AP2034A (en) 2009-08-28
ES2307662T3 (es) 2008-12-01
WO2002032445A3 (de) 2003-04-17
WO2002032445A2 (de) 2002-04-25
JP4881535B2 (ja) 2012-02-22
AP2003002795A0 (en) 2003-06-30
EP1328289B1 (de) 2008-09-03
JP2004511526A (ja) 2004-04-15
HK1057857A1 (en) 2004-04-23
EP1994941A3 (de) 2012-07-25
CA2453140C (en) 2016-01-05

Similar Documents

Publication Publication Date Title
DE60134866D1 (de) Verwendung von imidazochinolinaminen als adjuvantien in dna-impfung
NO20023043L (no) Substituerte oksazolidinoner og deres anvendelse innenfor feltet blodkoagulasjon
ATE355022T1 (de) Chirurgisches system mit griff und kanule
DK1141252T3 (da) Humant delta-5-desaturase-gen samt anvendelser deraf
DK1604679T3 (da) Anvendelse af botulinumtoksin ved behandlingen af viskeral smerte
ATE312636T1 (de) Infusion von flüssigkeiten in den menschlichen oder tierischen körper
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
ID26130A (id) Penyempurnaan-penyempurnaan dalam alat pengantar obat
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
NO20021964D0 (no) Biologisk fluidbehandling
ITTO20001156A0 (it) Apparecchiatura per il trattamento di disgregazione di campioni biologici e dispositivo disgregatore per l'impiego in detta apparecchiatura.
NO20001905D0 (no) Forbindelser og deres anvendelse i farmasøytiske eller kosmetiske preparater
ATA17962001A (de) Wölb-verwind-komfort- und therapie-stütze
NO20013102L (no) Gener, proteiner og deres anvendelse
DK1328289T3 (da) Oxiderede proteiner og deres biologiske og terapuetiske aktivitet samt diagnostisk anvendelse ved hæmning af interaktion mellem oxiderede proteiner og CD36
ATE291586T1 (de) Humanes antibiotisches protein
DE69526203D1 (de) Biologische zielgerichtete mittel
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
NO20021305L (no) DNA-konstruksjon og dens anvendelse
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
GB2349150B (en) Expression of DNA or proteins in C. Elegans
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
NO20030821D0 (no) Gener og proteiner, og deres anvendelse
NO990303L (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
ATE256754T1 (de) Gerbstoff-/nachgerbstoffpräparationen